In 2023, neurologists at a memory clinic in China diagnosed a 19-year-old with what they believed to be Alzheimer's disease, making him the youngest person ever to be diagnosed with the condition ...

In a novel breakthrough, scientists from China have reported positive and promising results from a new surgery, which aims to ...

Eisai and Biogen have a third regulatory approval for their amyloid-targeting Alzheimer’s disease therapy Leqembi, after it was greenlit by China’s National Medical Products Administration (NMPA).

A Chinese pharmaceutical company has developed a new drug for Alzheimer’s disease, the first such medication ... has already been approved for use by China’s drug authority – the National ...

due to Alzheimer’s disease (AD) and mild AD dementia. China is the third country to launch LEQEMBI following the United States and Japan. LEQEMBI selectively binds to soluble Aβ aggregates ...

Neurodegenerative diseases, such as Alzheimer's disease (AD), frontotemporal dementia ... Dried ZSS was sourced from Auropure LifeScience Co., Ltd. in China. The hot water extract was prepared ...